KELO.CELL at SISTERS BeautyPro in Hong Kong
KELO.CELL marks its presence in one of the most famous Hong Kong beauty industry fairs – SISTERS BeautyPro.
From the 16th to the 18th of May, in Hong Kong, more than 30,000 visitors had the opportunity to get to know the KELO.CELL brand, that being aware of people's daily well-being, has bet on innovation and is launching this year a new product line.
Since KELO.CELL Biogel has a unique and highly effective formulation for atrophic, hypertrophic and keloid scars, it was added SPF30, in KELO.CELL Protect, for sun protection and skin regeneration. With the KELO.CELL Concealer is guaranteed instant coverage of scars, which adapts to any skin tone and type. KELO.CELL PSORIS SOS Acute Balm and KELO.CELL PSORIS Body Lotion were produced to work together. They are essential allies for the fast and effective relief of the common signs and symptoms of psoriasis and dermatitis skin manifestations.
The KELO.CELL participation, in partnership with local distributor SENSEFORD BIOTECH, embraced business opportunities in a highly competitive market both within the scope of the pharmaceutical sector and in the geography to which it presented itself.
Discover about Kelo.Cell at www.kelocell.com
-
Innov.Cell ended its successful participation in CPHI 2024
Innov.Cell, a subsidiary of IGHS, ended its successful participation in CPHI 2024, which took place in Milan, with a positive outcome. This year, CPHI was attended by more than 62,000 people and around 2,400 exhibitors from 166 countries. Throughout the event, Innov.Cell met with several potential partners, from R&D, investors, and distributors covering more than 50 countries.
Read more -
OIH Introduces Revolutionary Treatment for Keratoconus: Corneal Allogeneic Intrastromal Ring Implants (CAIRS)
Oman International Hospital is thrilled to announce the successful introduction of a groundbreaking procedure designed to treat keratoconus: Corneal Allogeneic Intrastromal Ring Implants (CAIRS). This innovative treatment marks a significant advancement in ophthalmology, offering new hope to patients suffering from this debilitating corneal disorder.
Read more